What is Arcus Biosciences's revenue?

Arcus Biosciences (RCUS) generated $236.0M in revenue over the trailing twelve months, up 67.4% year over year.

Is Arcus Biosciences profitable?

Arcus Biosciences is not currently profitable: it reported a net loss of $369.0M over the trailing twelve months, a -156.4% net margin.

What is Arcus Biosciences's earnings per share?

Arcus Biosciences's diluted EPS over the trailing twelve months is $-3.19.

Where does Arcus Biosciences's income statement data come from?

Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Arcus Biosciences RCUS Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$236M-4.5%	$247M+2.9%	$240M-8.4%	$262M+85.8%	$141M-45.3%
Research and development	$523M0.0%	$523M+4.0%	$503M+3.7%	$485M+5.2%	$461M+2.9%
General and administrative	$111M+0.9%	$110M-1.8%	$112M-2.6%	$115M-0.9%	$116M-3.3%
Other operating expenses	$634M+0.2%	$633M+2.9%	$615M+2.5%	$600M+4.0%	$577M-1.9%
Total operating expenses	$634M+0.2%	$633M+2.9%	$615M+2.5%	$600M+4.0%	$577M-1.9%
Operating income	-$398M-3.1%	-$386M-2.9%	-$375M-10.9%	-$338M+22.5%	-$436M-32.1%
Operating margin	-168.6%-12.4pp	-156.3%0.0pp	-156.3%-27.2pp	-129%+180pp	-309.2%-181pp
Interest expense	$10M+25.0%	$8M0.0%	$8M+33.3%	$6M+50.0%	$4M0.0%
Other income (expense), net	$29M-12.1%	$33M-5.7%	$35M-14.6%	$41M-10.9%	$46M-4.2%
Income before income taxes	-$369M-4.5%	-$353M-3.8%	-$340M-14.5%	-$297M+23.8%	-$390M-38.3%
Income tax expense	$0—	$0-100%	$1M0.0%	$1M0.0%	$1M0.0%
Net income	-$369M-4.5%	-$353M-3.5%	-$341M-14.4%	-$298M+23.8%	-$391M-38.2%
Net margin	-156.4%-13.4pp	-142.9%-0.8pp	-142.1%-28.3pp	-113.7%+164pp	-277.3%-168pp
Diluted earnings per share	-$3.19+3.6%	-$3.31+3.8%	-$3.44-8.5%	-$3.17+24.3%	-$4.19-35.2%
Basic earnings per share	-$3.19+3.6%	-$3.31+3.8%	-$3.44-8.5%	-$3.17+24.3%	-$4.19-35.2%
Weighted-average shares, diluted	445.8M+6.4%	418.8M+4.3%	401.5M+3.9%	386.4M+4.2%	371M+3.4%
Weighted-average shares, basic	445.4M+6.5%	418.4M+4.3%	401.1M+3.9%	386M+4.0%	371M+3.4%
Interest and other income, net	$39M-4.9%	$41M-4.7%	$43M-8.5%	$47M-6.0%	$50M-3.8%
EBIT	-$398M-3.1%	-$386M-2.9%	-$375M-10.9%	-$338M+22.5%	-$436M-32.1%
EBITDA	-$389M-3.5%	-$376M-3.0%	-$365M-11.3%	-$328M+23.0%	-$426M-33.1%
EBITDA	-$389M-3.5%	-$376M-3.0%	-$365M-11.3%	-$328M+23.0%	-$426M-33.1%
EBITDA margin	-164.8%-12.6pp	-152.2%-0.1pp	-152.1%-26.9pp	-125.2%+177pp	-302.1%-178pp
EBIT	-$398M-3.1%	-$386M-2.9%	-$375M-10.9%	-$338M+22.5%	-$436M-32.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Arcus Biosciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's revenue?: Arcus Biosciences (RCUS) generated $236.0M in revenue over the trailing twelve months, up 67.4% year over year.
Is Arcus Biosciences profitable?: Arcus Biosciences is not currently profitable: it reported a net loss of $369.0M over the trailing twelve months, a -156.4% net margin.
What is Arcus Biosciences's earnings per share?: Arcus Biosciences's diluted EPS over the trailing twelve months is $-3.19.
Where does Arcus Biosciences's income statement data come from?: Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.